| RSV 6120/DeltaNS2/1030s |
LID/NIAID/NIH |
March 2019 |
|
| RSV DeltaNS2-Delta1313-I1314L |
LID/NIAID/NIH |
February 2019 |
|
| Selgantolimod (GS-9688) |
Gilead |
January 2023 |
|
| UVAX-1197 / UVAX-1107 - New - New |
Uvax Bio LLC |
January 2025 |
|
| V3G CH848 Pr-NP1, Adjuvanted and V3G CH848 mRNA-Tr2 |
VRC/NIAID/NIH |
September 2024 |
|
| Vesatolimod (GS-9620) |
Gilead |
April 2024 |
|
| VIR-1778 |
Vir Biotechnology |
May 2024 |
|
| VRC-HIVMAB060-00-AB (VRC01) |
VRC/NIAID |
August 2019 |
|
| VRC-HIVMAB075-00-AB (VRC07-523LS) |
VRC/NIAID/NIH |
April 2024 |
|
| VRC-HIVRGP096-00-VP (HIV-1 Trimer 4571 Vaccine) |
VRC/NIAID/NIH |
August 2023 |
|
